Gray Nancy Ryan

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Gray Nancy Ryan's trades of Ligand Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
404.52
Quantity 58,022 +0.6%
Value US$3,396,965
Transaction date
Sale
Price
166.91
Quantity 66,268 +35.5%
Value US$1,565,602
Transaction date
Proposed sale
Price
432.16
Quantity 83,561
Value US$2,342,845
Transaction date
Proposed sale
Price
83.20
Quantity 934
Value US$77,713
Transaction date
Proposed sale
Price
90.00
Quantity 831
Value US$74,790
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-12 2025-11-07
S Sale
58,022 +0.6%
404.52
US$3,396,965 		58,022 +0.6% 404.52 US$3,396,965
2025-11-12 2025-11-07
S Sale
66,268 +35.5%
166.91
US$1,565,602 		66,268 +35.5% 166.91 US$1,565,602
2025-11-07 2025-11-07
PrS Proposed sale
83,561
432.16
US$2,342,845 		83,561 432.16 US$2,342,845
2024-05-17 2024-05-09
S Sale
934 -14.2%
83.20
US$77,713 		934 -14.2% 83.20 US$77,713
2024-05-09 2024-05-09
PrS Proposed sale
934
83.20
US$77,713 		934 83.20 US$77,713
2024-02-28 2024-02-28
PrS Proposed sale
831
90.00
US$74,790 		831 90.00 US$74,790